Canadian Cancer Trials Group Bulletins

Trial Management Group


Permanent Trial Closures

The following two Intergroup-led trials have been permanently closed:

SR6 (TH-CR-406 / SARC021): A Randomized Phase 3, Multicenter, Open-Label Study Comparing TH-302 in Combination with Doxorubicin vs. Doxorubicin Alone in Subjects with Locally Advanced Unresectable or Metastatic Soft Tissue Sarcoma

PR8 (S9346): Phase III Study of Intermittent Androgen Deprivation in Patients With Stage D2 Prostate Cancer.

The notification to sites can be found under the "CCTG Toolbox" here: https://www.ctg.queensu.ca/trials/permanent_closure/permanent-trial-closure/.